The main purposes of the AIDA protocol are to test the role of intermittent maintenance
therapy with ATRA, standard maintenance chemotherapy with methotrexate and 6-mercaptopurine
of both in PCR negative patients at the end of the consolidation phase and to evaluate the
role of allogeneic or autologous bone marrow transplantation in PCR positive patients at the
end of the consolidation phase.